Quantitative susceptibility mapping for detection of kidney stones, hemorrhage differentiation, and cyst classification in ADPKD
Sign Up to like & getrecommendations! Published in 2024 at "Abdominal Radiology"
DOI: 10.1007/s00261-024-04243-6
Abstract: The objective is to demonstrate feasibility of quantitative susceptibility mapping (QSM) in autosomal dominant polycystic kidney disease (ADPKD) patients and to compare imaging findings with traditional T1/T2w magnetic resonance imaging (MRI). Thirty-three consecutive patients (11… read more here.
Keywords: adpkd; susceptibility mapping; hemorrhage; quantitative susceptibility ... See more keywords
Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatment
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-018-1542-x
Abstract: BackgroundSemaphorin 7A (SEMA7A) is an immunomodulating protein implicated in lung and liver fibrosis. In autosomal-dominant polycystic kidney disease (ADPKD), the progressive expansion of renal cysts, inflammation, and subsequent renal fibrosis leads to end-stage renal disease… read more here.
Keywords: fibrosis; disease; expression; tolvaptan treatment ... See more keywords
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-021-02111-x
Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic kidney disorder that impairs renal functions progressively leading to kidney failure. The disease affects between 1:400 and 1:1000 ratio of the people worldwide. It is caused… read more here.
Keywords: disease; autosomal dominant; dominant polycystic; polycystic kidney ... See more keywords
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Nephrology"
DOI: 10.1007/s40620-021-01131-w
Abstract: Causative mutations in the GANAB gene have been described in only 14 families, 9 diagnosed with late-onset Autosomal Dominant Polycystic Kidney Disease (ADPKD) and 5 with Autosomal Dominant Polycystic Liver Disease (ADPLD). Diagnosis of ADPKD… read more here.
Keywords: adpkd; ganab variant; family; adpkd ganab ... See more keywords
SO002INTERIM RESULTS FROM ACQUIRE: A STUDY MEASURING QUALITY OF LIFE, TREATMENT PREFERENCE AND TREATMENT SATISFACTION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS IN EUROPE
Sign Up to like & getrecommendations! Published in 2020 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaa139.so002
Abstract: Data suggest the health-related quality of life (HRQoL) of autosomal dominant polycystic kidney disease (ADPKD) patients (pts) may be lower than the general population [1,2]. In this ‘real life’ cohort of ADPKD pts with chronic… read more here.
Keywords: treatment; disease; treatment satisfaction; adpkd ... See more keywords
#1636 Treatment of Tolvaptan related polyuria with bendroflumethiazide for ADPKD: Does it really work?
Sign Up to like & getrecommendations! Published in 2024 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfae069.248
Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disease worldwide and accounts for 10% of patients on renal replacement therapy. Currently, the arginine vasopressin (AVP) V2 receptor antagonist Tolvaptan is the… read more here.
Keywords: treatment; adpkd; aquaretic side; tolvaptan ... See more keywords
#3742 Ketogenic diet as a therapeutic approach in ADPKD
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.0434
Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of kidney failure with very limited therapeutic options. Data from animal models show a large potential of ketogenic diets (KD) to ameliorate disease… read more here.
Keywords: ketosis; ketogenic diet; adpkd; approach ... See more keywords
#1375 Correlating symptom burden with polycystic liver volume progression in autosomal dominant polycystic kidney disease
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.1025
Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic kidney diseases leading to kidney failure and is usually due to pathogenic variants in either PKD1 or PKD2. The most common extrarenal… read more here.
Keywords: disease; progression; adpkd; pld ... See more keywords
#274 Genotype of autosomal dominant polycystic kidney disease in Greek patients
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.1055
Abstract: Genetic testing in patients with autosomal dominant polycystic kidney disease (ADPKD) provides critical information about the disease, enhances prognostic evaluation, and plays a vital role in patient management. This study aims to investigate the genetic… read more here.
Keywords: disease; etiology; adpkd; greek patients ... See more keywords
EPICARDIAL FAT THICKNESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCISTIC KIDNEY DISEASE
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000539317.33948.c3
Abstract: Objective: Autosomal dominant polycystic kidney disease (ADPKD) is associated with early organ damage such as left ventricular hypertrophy (LVH) and higher cardiovascular risk when compared to essential hypertension (EH). Epicardial adipose tissue (EAT) is a… read more here.
Keywords: adpkd; autosomal dominant; eat; kidney disease ... See more keywords
Rapamycin treatment dose‐dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell‐cycle‐associated CDK1/cyclin axis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.13091
Abstract: Although translational research into autosomal dominant polycystic kidney disease (ADPKD) and its pathogenesis has made considerable progress, there is presently lack of standardized animal model for preclinical trials. In this study, we developed an orthologous… read more here.
Keywords: adpkd; cyclin; model; cre ... See more keywords